![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lack of Effect of Oral Cabotegravir on the Pharmacokinetics of a Levonorgestrel/Ethinyl Estradiol Containing Oral Contraceptive in Healthy Adult Females
|
|
|
Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy
26 - 28 May 2015, Washington, DC, USA
C. Trezza1, S.L. Ford2, E. Gould3, Y. Lou4, C. Huang5, G. Bowers6, A. Buchanan1
1GlaxoSmithKline, Infectious Diseases Medicines Discovery and Development, Research Triangle Park, USA; 2GlaxoSmithKline, Clinical Pharmacology Modeling and Simulation, Research Triangle Park, USA; 3GlaxoSmithKline, Project Clinical Platforms and Sciences, Research Triangle Park, USA; 4GlaxoSmithKline, Clinical Statistics, Research Triangle Park, USA; 5PAREXEL International, Clinical Statistics, Carmel, USA; 6GlaxoSmithKline, Drug Metabolism and Pharmacokinetics, Research Triangle Park, USA
![pharm1.gif](../images/061215/061215-2/pharm1.gif)
![pharm2.gif](../images/061215/061215-2/pharm2.gif)
![pharm3.gif](../images/061215/061215-2/pharm3.gif)
![pharm4.gif](../images/061215/061215-2/pharm4.gif)
![pharm5.gif](../images/061215/061215-2/pharm5.gif)
![pharm6.gif](../images/061215/061215-2/pharm6.gif)
![pharm7.gif](../images/061215/061215-2/pharm7.gif)
![pharm8.gif](../images/061215/061215-2/pharm8.gif)
![pharm9.gif](../images/061215/061215-2/pharm9.gif)
![pharm10.gif](../images/061215/061215-2/pharm10.gif)
![pharm11.gif](../images/061215/061215-2/pharm11.gif)
![pharm12.gif](../images/061215/061215-2/pharm12.gif)
![pharm13.gif](../images/061215/061215-2/pharm13.gif)
![pharm14.gif](../images/061215/061215-2/pharm14.gif)
![pharm15.gif](../images/061215/061215-2/pharm15.gif)
![pharm16.gif](../images/061215/061215-2/pharm16.gif)
![pharm17.gif](../images/061215/061215-2/pharm17.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|